Trial intelligence / Profile preview

NORTHIV: Comparison of ART Regimens in Naïve HIV Patients

NCT01445223Phase 4Completed

Sponsor
University of Gothenburg
Start
Apr 2004
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of lopinavir, atazanavir, efavirenz in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Gothenburg. Started Apr 2004; status: completed.

02

Drugs

lopinaviratazanavirefavirenz
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01445223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01445223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call